Dementia of Alzheimer Type

6

Review clinical trials related to Dementia of Alzheimer Type. Use filters to narrow results by trial status, phase, treatment, biological sex and sponsor.

Condition / disease
Location
Status: Recruiting

Characterizing Variability in Hearing Aid Outcomes in Among Older Adults With Alzheimer's Dementia

This current translational project, funded by NIH, aims to better understand the impact of various signal modification strategies for older adults with Alzheimer's dementia and its potential precursor, known as amnestic mild cognitive impairment. The investigators hypothesize that adults with Alzheimer's dementia represent an extreme case of restricted cognitive ability, such that very low working memory capacity and overall reduced cognitive capacity will limit benefit from advanced signal processing. Thus, the investigators hypothesize that adults with Alzheimer's dementia will receive greater benefit from acoustically simple, high-fidelity hearing aid processing that minimally alters the acoustic signal.

Participants needed: 20
Trial details
Age: 50-90Biological sex: AllType: InterventionalSponsor: Northwestern UniversityUpdated: Apr 30, 2026Locations: 2
Eligibility criteria

Speak English as their primary language [+7]

Clinically significant unstable or progressive medical conditions, or conditions... [+5]

Status: Recruiting

Assess Fibrin in Brains With AD/ADRD

The goal of this project is to quantify brain fibrin content using 64Cu-FBP8-PET in the brains of subjects ranging from cognitively normal to clinically diagnosed with ADRD to evaluate potential regional differences.

Participants needed: 30
Trial details
Phase: Phase 1, Phase 2Age: 55-90Biological sex: AllType: InterventionalSponsor: Massachusetts General HospitalUpdated: Oct 30, 2025Locations: 1
Eligibility criteria

Age between 55 and 90 years [+4]

MR contraindications such as: electrical implants such as cardiac pacemakers or... [+4]

Status: Recruiting

Autonomic Involvement in Patient With Cognitive Decline

Prospective interventional study with a device for comparing autonomic parameters among patients with different forms of cognitive decline

Participants needed: 120
Trial details
Age: 50-85Biological sex: AllType: InterventionalSponsor: Fondazione Policlinico Universitario Agostino Gemelli IRCCSUpdated: Aug 26, 2025Locations: 1
Eligibility criteria

male and females between 50 and 85 years [+3]

diabetes mellitus [+7]

Status: Recruiting

Reducing African American's Alzheimer's Risk Through Exercise-Mild Cognitive Impairment (RAATE-MCI)

The RAATE-MCI proposal is designed to determine the effects of physical activity on risk factors for Alzheimer's Disease in older African American adults. The study will compare a physical activity program to an active control group. RAATE-MCI is a 52-week randomized controlled trial. 144 African American adults aged 60 and older will be recruited.

Participants needed: 144
Trial details
Age: 60+Biological sex: AllType: InterventionalSponsor: Pennington Biomedical Research CenterUpdated: Mar 17, 2025Locations: 1
Eligibility criteria

are African American (self-identify) [+13]

have cognitive impairment that would interfere with participating in a group dis... [+14]

Status: Recruiting

Uppsala-Dalarna Dementia and Gait Project

UDDGait™ is a multidisciplinary research project with the overreaching goal of providing an aid for early identification of cognitive impairment and risk of dementia development, thereby providing a basis for adequate symptom relieving and health promoting interventions. A new concept is investigated for this purpose: a "dual-task-test", which implies the combination of a well-established mobility test (Timed Up-and-Go, TUG) with a simultaneous verbal task (i.e. TUG dual-task, TUGdt). This type of test has been judged as a potential aid for early identification of dementia disease. More research is needed to further examine the test's validity, reliability and predictive capacity. The overall aim is to investigate if TUGdt is useful as an aid for prediction of dementia disease. To ensure the results, the aim is also to evaluate the test's measurement properties and to generate normative reference values of healthy control persons.

Participants needed: 550
Trial details
Age: 37-94Biological sex: AllType: ObservationalSponsor: Dalarna UniversityUpdated: Feb 12, 2025Locations: 2
Eligibility criteria

Patients undergoing memory assessment at at Uppsala University Hospital, Sweden [+2]

Inability to walk three meters back and forth [+4]

Status: Not yet recruiting

An Observational Study of Patients Living With Chronic Neurological Diseases

TARGET-NEURO is an observational research study to conduct a comprehensive review of outcomes for patients living with chronic neurological diseases: Alzheimer's disease and related dementia (ADRD), mild cognitive impairment (MCI), Parkinson's disease (PD), and multiple sclerosis (MS).

Participants needed: 1,500,000
Trial details
Age: 18+Biological sex: AllType: ObservationalSponsor: Target PharmaSolutions, Inc.Updated: Nov 20, 2024
Eligibility criteria

Death [+13]